Predictors of Response to Vedolizumab in Patients with Ulcerative Colitis: Results from the Greek VEDO-IBD Cohort
Bamias Giorgos,Kokkotis Georgios,Gizis Michalis,Kapizioni Christina,Karmiris Konstantinos,Koureta Evgenia,Kyriakos Nikolaos,Leonidakis Georgios,Makris Konstantinos,Markopoulos Panagiotis,Michalopoulos Georgios,Michopoulos Spyridon,Papaconstantinou Ioannis,Polymeros Dimitrios,Siakavellas Spyros I.,Triantafyllou Konstantinos,Tsironi Eftychia,Tsoukali Emmanouela,Tzouvala Maria,Viazis Nikos,Xourafas Vassileios,Zacharopoulou Eirini,Zampeli Evanthia,Zografos Konstantinos,Papatheodoridis George,Mantzaris Gerasimos Digestive Diseases and Sciences（2021）
Key words
Efficacy,Clinical remission,Treatment persistence,Mucosal healing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper